Patents by Inventor Don B. Gammon

Don B. Gammon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncolytic viruses and methods for treating neoplastic disorders
    Patent number: 9370550
    Abstract: The disclosure provides mutant ribonucleotide reductase strains of poxviruses including for example vaccinia viruses. The disclosure also provides methods and for the use of these mutant ribonucleotide reductase strains of vaccinia viruses in oncolytic virotherapy. Also provided in the disclosure are vector constructs for generating mutant ribonucleotide reductase strains of poxviruses including for example vaccinia viruses. The disclosure also provides poxviruses comprising a functionally inactivated R2 gene.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: June 21, 2016
    Assignee: The Governors of the University of Alberta
    Inventors: David H. Evans, Don B. Gammon
  • Oncolytic Viruses and Methods for Treating Neoplastic Disorders
    Publication number: 20140234257
    Abstract: The disclosure provides mutant ribonucleotide reductase strains of poxviruses including for example vaccinia viruses. The disclosure also provides methods and for the use of these mutant ribonucleotide reductase strains of vaccinia viruses in oncolytic virotherapy.
    Type: Application
    Filed: January 28, 2014
    Publication date: August 21, 2014
    Applicant: The Governors of the University of Alberta
    Inventors: David H. Evans, Don B. Gammon
  • Oncolytic viruses and methods for treating neoplastic disorders
    Patent number: 8679509
    Abstract: The disclosure provides mutant ribonucleotide reductase strains of poxviruses including for example vaccinia viruses. The disclosure also provides methods and for the use of these mutant ribonucleotide reductase strains of vaccinia viruses in oncolytic virotherapy.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: March 25, 2014
    Assignee: The Governors of the University of Alberta
    Inventors: David H. Evans, Don B. Gammon
  • Oncolytic Viruses And Methods For Treating Neoplastic Disorders
    Publication number: 20120114612
    Abstract: The disclosure provides mutant ribonucleotide reductase strains of poxviruses including for example vaccinia viruses. The disclosure also provides methods and for the use of these mutant ribonucleotide reductase strains of vaccinia viruses in oncolytic virotherapy.
    Type: Application
    Filed: July 9, 2010
    Publication date: May 10, 2012
    Inventors: David H. Evans, Don B. Gammon